ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza
Conditions: Influenza; Influenza, Human Interventions: Drug: Drug: Oseltamivir; Drug: Drug: Favipiravir; Drug: Drug: Zanamivir; Drug: Drug: Baloxavir; Drug: Drug: Molnupiravir; Drug: Drug: Peramivir; Drug: Drug: Laninamivir Sponsor: University of Oxford Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials